NCT00325650View on ClinicalTrials.gov

Rimonabant In Prediabetic Subjects To Delay Onset Of Type 2 Diabetes

PHASE3TerminatedINTERVENTIONAL

Enrollment

2,420

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions

Prediabetic State

Interventions

DRUG

Rimonabant

Tablet, oral administration

DRUG

Placebo (for Rimonabant)

Tablet, oral administration

Trial Locations (1)

08807

Sanofi-Aventis, Bridgewater

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY

NCT00325650 - Rimonabant In Prediabetic Subjects To Delay Onset Of Type 2 Diabetes | Biotech Hunter | Biotech Hunter